| 11/04/2026 3:08 PM | Arcus Biosciences (1724521) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/04/2026 3:10 PM | Arcus Biosciences (1724521) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 10/23/2026 3:12 PM | Arcus Biosciences (1724521) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/22/2026 3:05 PM | Arcus Biosciences (1724521) Filer | Form 424B5 | |
| 10/21/2026 3:30 PM | Arcus Biosciences (1724521) Filer | Form 424B5 | |
| 10/21/2026 3:09 PM | Arcus Biosciences (1724521) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/20/2026 7:33 AM | Arcus Biosciences (1724521) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/28/2026 1:13 PM | Arcus Biosciences (1724521) Filer | Form CT ORDER | |
| 08/24/2026 4:52 PM | Arcus Biosciences (1724521) Issuer Azoy Alexander (1771961) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/21/2026 3:36 PM | Arcus Biosciences (1724521) Subject Azoy Alexander (1771961) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/05/2026 3:11 PM | Arcus Biosciences (1724521) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
Get the Latest News and Ratings for RCUS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Arcus Biosciences and its competitors with MarketBeat's FREE daily newsletter.
|
| 07/13/2026 4:36 PM | Arcus Biosciences (1724521) Issuer Jaen Juan C. (1422996) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/09/2026 5:31 PM | Arcus Biosciences (1724521) Subject Jaen Juan C. (1422996) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/24/2026 5:17 PM | Arcus Biosciences (1724521) Subject Jaen Juan C. (1422996) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/24/2026 4:41 PM | Arcus Biosciences (1724521) Issuer Jaen Juan C. (1422996) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/22/2026 5:31 PM | Arcus Biosciences (1724521) Subject Jaen Juan C. (1422996) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/01/2026 6:23 PM | Arcus Biosciences (1724521) Issuer Azoy Alexander (1771961) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/11/2026 4:33 PM | Arcus Biosciences (1724521) Subject Goeltz II Robert C. (1653881) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/23/2026 3:46 PM | Arcus Biosciences (1724521) Subject Jarrett Jennifer (1671311) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/21/2026 3:06 PM | Arcus Biosciences (1724521) Filer | Form DEF 14A | |
| 04/20/2026 6:56 AM | Arcus Biosciences (1724521) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/08/2026 3:21 PM | Arcus Biosciences (1724521) Subject Jarrett Jennifer (1671311) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/26/2026 2:45 PM | Arcus Biosciences (1724521) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/23/2026 6:46 AM | Arcus Biosciences (1724521) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/25/2026 3:20 PM | Arcus Biosciences (1724521) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 01/26/2026 7:21 PM | Arcus Biosciences (1724521) Issuer Jarrett Jennifer (1671311) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/26/2026 7:21 PM | Arcus Biosciences (1724521) Issuer Azoy Alexander (1771961) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/26/2026 7:21 PM | Arcus Biosciences (1724521) Issuer Goeltz II Robert C. (1653881) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/26/2026 7:21 PM | Arcus Biosciences (1724521) Issuer Tang Carolyn C. (1836662) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/26/2026 7:21 PM | Arcus Biosciences (1724521) Issuer Jaen Juan C. (1422996) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/26/2026 7:21 PM | Arcus Biosciences (1724521) Issuer ROSEN TERRY J (1182473) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/26/2026 7:21 PM | Arcus Biosciences (1724521) Issuer Markus Richard (2056093) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/09/2026 3:26 PM | Arcus Biosciences (1724521) Issuer ROSEN TERRY J (1182473) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/08/2026 12:28 PM | Arcus Biosciences (1724521) Subject BlackRock, Inc. (2012383) Filed by | Form SCHEDULE 13G/A | |
| 01/07/2026 3:15 PM | Arcus Biosciences (1724521) Issuer Jaen Juan C. (1422996) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/02/2026 3:18 PM | Arcus Biosciences (1724521) Issuer ROSEN TERRY J (1182473) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/02/2026 3:19 PM | Arcus Biosciences (1724521) Issuer Goeltz II Robert C. (1653881) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/31/2025 5:26 PM | Arcus Biosciences (1724521) Subject Goeltz II Robert C. (1653881) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/18/2025 4:35 PM | Arcus Biosciences (1724521) Issuer ROSEN TERRY J (1182473) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/18/2025 4:35 PM | Arcus Biosciences (1724521) Issuer Jaen Juan C. (1422996) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/18/2025 4:35 PM | Arcus Biosciences (1724521) Issuer Jarrett Jennifer (1671311) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Your free book is about to disappear (Ad) Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link.
He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing. Download the Safe Trade Options Formula book for free before access closes |
| 12/18/2025 4:35 PM | Arcus Biosciences (1724521) Issuer Goeltz II Robert C. (1653881) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/18/2025 4:35 PM | Arcus Biosciences (1724521) Issuer Azoy Alexander (1771961) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/18/2025 4:35 PM | Arcus Biosciences (1724521) Issuer Markus Richard (2056093) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/18/2025 4:35 PM | Arcus Biosciences (1724521) Issuer Tang Carolyn C. (1836662) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/18/2025 3:23 PM | Arcus Biosciences (1724521) Subject Azoy Alexander (1771961) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/15/2025 5:19 PM | Arcus Biosciences (1724521) Subject ROSEN TERRY J (1182473) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/15/2025 5:20 PM | Arcus Biosciences (1724521) Subject Jaen Juan C. (1422996) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/15/2025 5:21 PM | Arcus Biosciences (1724521) Subject Jarrett Jennifer (1671311) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/15/2025 5:21 PM | Arcus Biosciences (1724521) Subject Goeltz II Robert C. (1653881) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/15/2025 5:22 PM | Arcus Biosciences (1724521) Subject Azoy Alexander (1771961) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/15/2025 5:22 PM | Arcus Biosciences (1724521) Subject Tang Carolyn C. (1836662) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/15/2025 5:23 PM | Arcus Biosciences (1724521) Subject Markus Richard (2056093) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/12/2025 7:34 AM | Arcus Biosciences (1724521) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/04/2025 4:10 PM | Arcus Biosciences (1724521) Subject Jaen Juan C. (1422996) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/01/2025 5:09 PM | Arcus Biosciences (1724521) Issuer Azoy Alexander (1771961) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/26/2025 3:20 PM | Arcus Biosciences (1724521) Subject Azoy Alexander (1771961) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/26/2025 2:12 PM | Arcus Biosciences (1724521) Subject Goeltz II Robert C. (1653881) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |